Confidence: 85%
B083G9K6M5
View on Amazon →Decision summary
Not a strong option overall. The product is materially held back by weaker formulation coherence.
Best for
Only budget-focused buyers with flexible standards.
Consider another option if
You care a lot about label clarity and want fewer unknowns.
Score breakdown
Tap a module to see what it measures. A 0 can reflect missing disclosure, not just a negative result.
Dosage quality
3.1/10Dosing looks weaker than ideal
Checks whether labeled ingredient amounts fall within clinically studied ranges (not just regulatory minimums). Low/0 can reflect under-dosing or missing amounts (e.g., proprietary blends).
Explore next
The formula stays relatively clean on excipients. The main limitation is that epa: below clinically studied range.
Strengths
Weaknesses
Final verdict
Not a strong option overall. The product is materially held back by weaker formulation coherence.
A closer look at the main ingredients, how they influence the score, and the supporting evidence when available. Tap any ingredient to expand.
ℹ Evidence is strong, but dose is below the optimal range
This is a limiting factor: Dose is below the ranges usually used for stronger effects. The label does not specify the form, so absorption quality cannot be verified.
Scientific evidence
Yurko-Mauro et al. RCT DHA and memory in age-related decline
Alzheimer's & Dementia • 2010
PMID: 20439549.0
ℹ Evidence is strong, but dose is below the optimal range
This is a limiting factor: Dose is likely below clinically useful levels. The label does not specify the form, so absorption quality cannot be verified.
Scientific evidence
Fortin et al. meta-analysis omega-3 and rheumatoid arthritis
Journal of Rheumatology • 2000
PMID: 12480795.0
Bhatt et al. REDUCE-IT trial EPA and cardiovascular events
New England Journal of Medicine • 2019
PMID: 31141425.0
⚠ Moderate evidence exists, but dose is below effective threshold
A clear drag on the formula: Dose is likely below clinically useful levels.
Scientific evidence
Fakhri et al. meta-analysis astaxanthin and oxidative stress
Antioxidants • 2021
PMID: 33924894.0
Tominaga et al. RCT astaxanthin and skin wrinkles
Acta Biochimica Polonica • 2012
PMID: 22428137.0
Evidence inferred from established knowledge, not directly linked studies
Adequate, but not a key strength: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Evidence inferred from established knowledge, not directly linked studies
Adequate, but not a key strength: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Important label or formulation details that may affect how this product should be interpreted.
Epa dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Epa form is not clearly declared
Exact ingredient form is not disclosed on the label.
Dha form is not clearly declared
Exact ingredient form is not disclosed on the label.
Read our methodology overview to understand how SuppScoreLab combines multiple scientific dimensions into one practical score.
View methodology →This evaluation is based on the product label and declared Supplement Facts available at review time. It does not verify laboratory-tested composition, purity, or batch-level quality. This content is educational and not medical advice. Consult a qualified healthcare professional for personal health decisions. Affiliate disclosure: SuppScoreLab may earn a commission from qualifying Amazon links.
See the best Omega-3 supplements ranked with the same methodology, or keep exploring the database.
